Novel cardiovascular therapeutics and the risk of financial toxicity.
Publication
, Journal Article
Gunn, AH; Pendyal, A
Published in: Nat Rev Cardiol
June 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
June 2024
Volume
21
Issue
6
Start / End Page
349 / 350
Location
England
Related Subject Headings
- Humans
- Drug Costs
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiovascular Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Gunn, A. H., & Pendyal, A. (2024). Novel cardiovascular therapeutics and the risk of financial toxicity. Nat Rev Cardiol, 21(6), 349–350. https://doi.org/10.1038/s41569-024-01010-4
Gunn, Alexander H., and Akshay Pendyal. “Novel cardiovascular therapeutics and the risk of financial toxicity.” Nat Rev Cardiol 21, no. 6 (June 2024): 349–50. https://doi.org/10.1038/s41569-024-01010-4.
Gunn AH, Pendyal A. Novel cardiovascular therapeutics and the risk of financial toxicity. Nat Rev Cardiol. 2024 Jun;21(6):349–50.
Gunn, Alexander H., and Akshay Pendyal. “Novel cardiovascular therapeutics and the risk of financial toxicity.” Nat Rev Cardiol, vol. 21, no. 6, June 2024, pp. 349–50. Pubmed, doi:10.1038/s41569-024-01010-4.
Gunn AH, Pendyal A. Novel cardiovascular therapeutics and the risk of financial toxicity. Nat Rev Cardiol. 2024 Jun;21(6):349–350.
Published In
Nat Rev Cardiol
DOI
EISSN
1759-5010
Publication Date
June 2024
Volume
21
Issue
6
Start / End Page
349 / 350
Location
England
Related Subject Headings
- Humans
- Drug Costs
- Cardiovascular System & Hematology
- Cardiovascular Diseases
- Cardiovascular Agents